Jean-Charles Soria to Adenocarcinoma
This is a "connection" page, showing publications Jean-Charles Soria has written about Adenocarcinoma.
Connection Strength
0.172
-
Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy. J Clin Oncol. 2017 Jun 20; 35(18):2018-2027.
Score: 0.101
-
Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Clin Cancer Res. 2012 May 01; 18(9):2443-51.
Score: 0.071